“Proteomics Market” by Manufacturers, Regions, Type and Application, forecast to 2022

Posted on Updated on


Summary: Proteomics Market Report, published by Allied Market Research. Proteomics has the capacity to explain questions that were unsolved by genomics, as proteins are the functional unit of cells.

Proteomics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $44,452 million by 2022, registering a CAGR of 13.7% during the period 2014 – 2022.Instruments segment is expected to dominate the global market throughout the forecast period. North America held the leading position in the global market in 2015, and is expected to maintain this trend.

Click here to request sample copy of report: https://www.alliedmarketresearch.com/request-free-sample/1677

The key drivers of the market include increased R&D funding by leading players and government agencies, such as National Institutes of Health (NIH) and National Science Foundation (NSF), and technological advancements, such as development of dual mass analyzers (for instance LC/MS, GC/MS, FT-MS, and MALDI-TOF/TOF) and improvements in the liquid chromatography & gel electrophoresis procedures. Also, the increase in popularity of personalized medicines is set to propel the market. However, high cost of the instruments and dearth of skilled researchers hamper the market growth.

Protein microarray generated the highest revenue in 2015, owing to the high usage rates of this technology as it tracks protein interactions in lesser time as compared to other technologies. In the reagents segment, immunoassays generated the highest revenue in 2015 as these are extensively utilized in primary screening in drug discovery and microarray technologies. On the basis of applications, drug discovery accounted for the major share of the overall market in 2015.

Enquire here to get discount on report: https://www.alliedmarketresearch.com/get-discount/1677

North America held the largest share of about two-fifth of the market in 2015. The increase in popularity and adoption of personalized medicines and favorable government funding and initiatives are the key factors that drive the market growth in this region. However, Asia-Pacific is expected to grow at a CAGR of 17.0% from 2016 to 2022. The rise in prevalence of chronic diseases and increase in interest of researchers to utilize proteomics in the disease diagnosis and treatment are expected to fuel the market growth.

Key players profiled in this report include Thermo Fisher Scientific Corporation, Agilent Technologies, Luminex Corporation, Danaher Corporation, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Waters Corporation, Caprion Proteomics, Inc., PerkinElmer, Inc., and Bruker Corporation.

Browse complete report: https://www.alliedmarketresearch.com/proteomics-market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact Us:

5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
United States.
Int’l:       +1-503-894-6022
Toll Free:   +1-800-792-5285
Fax:   +1-800-792-5285

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s